Drugs Made In America Acquisition Corp
DMAAR0.123USD
-0.007-5.69%
交易中 （美东）报价延迟15分钟
0.00总市值
--市盈率 TTM
关于 Drugs Made In America Acquisition Corp 公司
Drugs Made In America Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The Company intends to focus its search for businesses in the pharmaceutical industry. The Company has neither engaged in any operations nor generated any revenues.
Drugs Made In America Acquisition Corp简介
公司代码DMAAR
公司名称Drugs Made In America Acquisition Corp
上市日期Jan 28, 2025
CEOStockwell (Lynn)
员工数量- -
证券类型Right
年结日- -
公司地址1 East Broward Boulevard
城市FT LAUDERDALE
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编33301
电话19548703099
网址
公司代码DMAAR
上市日期Jan 28, 2025
CEOStockwell (Lynn)
Drugs Made In America Acquisition Corp公司高管
名称
名称/职务
职务
持股
持股变动
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director Nominee
Independent Director Nominee
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
名称
名称/职务
职务
持股
持股变动
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director Nominee
Independent Director Nominee
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
收入明细
由于公司未披露，未能获取相关数据
由于公司未披露，未能获取相关数据
业务
地区
由于公司未披露，未能获取相关数据
股东统计
更新时间: 11月17日 周一
更新时间: 11月17日 周一
持股股东
股东类型
持股股东
持股股东
占比
其他
100.00%
持股股东
持股股东
占比
其他
100.00%
股东类型
持股股东
占比
其他
100.00%
机构持股
更新时间: 12月8日 周一
更新时间: 12月8日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q4
40
17.87M
0.00%
-452.02K
2025Q3
40
18.00M
0.00%
-473.40K
2025Q2
29
18.49M
0.00%
+4.36M
2025Q1
20
14.06M
0.00%
+14.06M
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
TD Securities, Inc.
1.00M
0%
-945.60K
-48.60%
Sep 30, 2025
Harraden Circle Investments, LLC
1.50M
0%
--
--
Sep 30, 2025
Boothbay Fund Management, LLC
570.00K
0%
--
--
Sep 30, 2025
Mangrove Partners
850.00K
0%
--
--
Sep 30, 2025
ATW Spac Management LLC
570.00K
0%
--
--
Sep 30, 2025
Westchester Capital Management, LLC
500.00K
0%
--
--
Sep 30, 2025
Polar Asset Management Partners Inc.
1.90M
0%
--
--
Sep 30, 2025
Glazer Capital, LLC
588.30K
0%
-711.70K
-54.75%
Sep 30, 2025
Clear Street LLC
672.09K
0%
+121.91K
+22.16%
Jun 30, 2025
LMR Partners LLP
500.00K
0%
--
--
Sep 30, 2025
查看更多
持股ETF
更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
CrossingBridge Pre-Merger SPAC ETF
0%
CrossingBridge Pre-Merger SPAC ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
